Literature DB >> 2172456

Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine.

M Eloit1, P Gilardi-Hebenstreit, B Toma, M Perricaudet.   

Abstract

The gene encoding the pseudorabies virus glycoprotein gp50 was cloned at the very left end of the genome of adenovirus type 5 to give a recombinant adenovirus (Ad-gp50) defective for the E1A gene. Ad-gp50 expressed high levels of gp50 in cells which either complemented (293 cells) or did not complement (Vero and HeLa cells) the E1A gene. Surprisingly, over an extended period, higher levels of gp50 were produced in HeLa cells which lack the E1A gene. Rabbits and mice inoculated with Ad-gp50 showed a strong antibody response against gp50. Some of them were protected from a virulent challenge with pseudorabies virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172456     DOI: 10.1099/0022-1317-71-10-2425

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection.

Authors:  X J Da Costa; C A Jones; D M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 2.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

3.  Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus.

Authors:  M Eloit; P Vannier; E Hutet; A Fournier
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 4.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

5.  In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.

Authors:  Hyun Ju Lee; Cheol Yi Hong; Mi Hyun Kim; Youn Kyung Lee; Thanh Nhan Nguyen-Pham; Byoung Chul Park; Deok Hwan Yang; Ik Joo Chung; Hyeoung Joon Kim; Je Jung Lee
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

6.  Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen.

Authors:  X S He; H S Chen; K Chu; M Rivkina; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

7.  Use of Staby(®) technology for development and production of DNA vaccines free of antibiotic resistance gene.

Authors:  Anca Reschner; Sophie Scohy; Gaëlle Vandermeulen; Marc Daukandt; Céline Jacques; Benjamin Michel; Hans Nauwynck; Florence Xhonneux; Véronique Préat; Alain Vanderplasschen; Cédric Szpirer
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

8.  Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network.

Authors:  Y Zhang; R J Schneider
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

Review 9.  Genetic vaccines--a revolution in vaccinology?

Authors:  Z Q Xiang; S Pasquini; Z He; H Deng; Y Wang; M A Blaszczyk-Thurin; H C Ertl
Journal:  Springer Semin Immunopathol       Date:  1997

10.  High level of transgene expression in cell cultures and in the mouse by replication-incompetent adenoviruses harboring modified VAI genes.

Authors:  M Eloit; M Adam; I Gallais; A Fournier
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.